Patent · US Active

Method for increasing the bioavailability of glycopyrrolate

US7816396B1 · kind B1 · utility

0Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2009
Grant dateOct 19, 2010
Priority date
Expiry dateDec 28, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.